Earnouts & Contingent Consideration

💡 Core Truth About Earnouts
Earnouts are often the source of post-close disputes. While they can bridge valuation gaps and align incentives, they must be carefully structured with clear, objective metrics and dispute resolution mechanisms.

Earnouts are performance-based payments made to sellers after closing, contingent on the business achieving specified financial or operational targets. This guide covers how to structure, negotiate, and manage earnouts effectively.

What is an Earnout?

Definition: Contingent consideration paid to the seller based on the acquired business's post-closing performance over a specified period.

Formula:

Total Purchase Price = Base Payment (at close) + Earnout (if targets met)

Example:

$60M paid at close
+ Up to $20M earnout over 2 years if revenue targets met
= $60-80M total consideration

Why Use Earnouts?

🤝

Bridge Valuation Gaps

Most Common Reason

Buyer thinks company worth $60M, seller wants $80M. Earnout bridges the $20M gap based on future performance.

📈

Align Incentives

Keep Seller Motivated

Seller stays engaged and drives performance during transition period, ensuring business momentum continues.

⚖️

Share Risk

Risk Mitigation

Buyer reduces risk of overpaying if business underperforms. Seller gets upside if business exceeds expectations.

🔄

Transition Management

Retention Tool

Ensures seller/management stays through critical transition period, often 12-36 months.

Earnout Statistics

Market Data on Earnouts

25-35%
Of M&A deals include earnouts
15-40%
Typical earnout as % of total deal value
2-3 years
Most common earnout period
~50%
Of earnouts result in disputes

Earnout Metrics: What to Measure

Revenue-Based Earnouts

Definition: Payment based on achieving revenue targets

Example Structure:

Year 1: $5M if revenue ≥ $70M
Year 2: $5M if revenue ≥ $85M
Year 3: $10M if cumulative revenue ≥ $260M

Pros:

  • Objective and easy to measure
  • Less susceptible to buyer manipulation
  • Clear definition
  • Aligns with growth objectives

Cons:

  • Seller may prioritize revenue over profitability
  • Doesn't account for margin erosion
  • Can incentivize unprofitable growth

Best For: High-growth companies, SaaS businesses, situations where growth is primary objective

Typical Metric: Annual revenue, ARR (for SaaS), bookings

EBITDA-Based Earnouts

Definition: Payment based on achieving EBITDA/profitability targets

Example Structure:

Year 1: $3M if EBITDA ≥ $15M
Year 2: $4M if EBITDA ≥ $18M
Total earnout = Actual EBITDA × 2.5x multiple (capped at $10M)

Pros:

  • Balances growth and profitability
  • Standard M&A metric
  • Reflects operational performance
  • Common in mature businesses

Cons:

  • Highly susceptible to buyer manipulation (expense allocation, accounting policies)
  • Complex to define precisely
  • Subject to interpretation disputes
  • Buyer controls cost structure

Best For: Mature, profitable businesses where maintaining margins is key

Critical: Requires extremely detailed definition of EBITDA calculation and protections against manipulation

Gross Profit / Gross Margin

Definition: Payment based on gross profit or maintaining margins

Example Structure:

Earnout = 20% × Gross Profit over 2 years, capped at $15M
Minimum threshold: 70% gross margin maintained

Pros:

  • Less manipulable than EBITDA (fewer expense allocations)
  • Focuses on core business performance
  • Protects against margin erosion

Cons:

  • Still requires clear definition of COGS
  • Buyer can influence through pricing
  • Less common metric (harder to benchmark)

Best For: Businesses with clear gross margin definition, product companies

Operational/Milestone-Based

Definition: Payment based on achieving specific operational milestones

Example Structure:

$5M if FDA approval obtained by Year 2
$3M if 100 new customers added in Year 1
$2M if key product launched on schedule

Pros:

  • Objective, binary outcomes
  • Less susceptible to accounting manipulation
  • Aligns with specific strategic goals
  • Works for early-stage companies

Cons:

  • May not reflect financial value
  • Can be impacted by buyer actions
  • All-or-nothing outcomes

Best For: Biotech/pharma (regulatory milestones), technology (product launches), early-stage companies

Earnout Structure Components

1. Performance Period

Period Typical Use Case Considerations
1 Year Short-term uncertainty, specific milestones Quick resolution, but may not capture full value
2-3 Years Most common, balances time and value Longer seller involvement, reasonable forecast period
4-5 Years Long development cycles (pharma, large projects) Hard to forecast, seller tied up for long period

2. Payment Structure

Binary (All-or-Nothing):

Hit $20M EBITDA target → Earn $10M
Miss target → Earn $0
  • Simple, clear
  • High risk for seller
  • Creates "cliff" effects

Sliding Scale (Linear):

Revenue Scale:
< $60M: $0
$60-80M: $500K per $1M of revenue above $60M
> $80M: $10M (cap)
  • More nuanced, fair
  • Rewards partial achievement
  • Reduces gaming behavior

Tiered (Stepped):

EBITDA Tiers:
$12-14M: $5M earnout
$14-16M: $7M earnout
$16M+: $10M earnout
  • Clear targets
  • Motivates reaching tiers
  • Can create gaming at tier boundaries

3. Threshold, Target, and Cap

Threshold (Floor)

Minimum performance needed for any earnout payment

Example: $15M EBITDA minimum

Target

Expected performance level for full earnout

Example: $18M EBITDA = $10M earnout

Cap (Ceiling)

Maximum earnout payment regardless of performance

Example: Capped at $15M total

Buyer Protections & Controls

Earn out Calculation Methodology

Critical: The earnout calculation methodology is the most disputed aspect. Define it with extreme precision.

Key Elements to Define:

  1. Accounting Standards: GAAP, IFRS, or seller's historical practices?
  2. Expense Allocations: Which corporate overhead is allocated? How much?
  3. Revenue Recognition: When is revenue recognized? What about deferred revenue?
  4. Extraordinary Items: How are one-time gains/losses treated?
  5. Capital Expenditures: Who decides on capex? Are they excluded from EBITDA?
  6. Working Capital: How are AR/AP changes handled?

Example Clause:

"EBITDA shall be calculated consistent with seller's historical accounting practices,
except that: (i) corporate overhead allocation shall not exceed $500K annually;
(ii) extraordinary items over $100K shall be excluded; (iii) calculation shall be
subject to independent audit by [Accounting Firm]"

Operational Control During Earnout

Key Considerations:

Buyer Wants: Full control to optimize integrated business

Seller Wants: Sufficient autonomy to achieve earnout targets

Typical Compromise:

  • Buyer has full operational control
  • Buyer agrees to operate business consistent with past practices
  • Buyer cannot take actions specifically designed to reduce earnout
  • Seller input on major strategic decisions affecting earnout
  • Covenant not to take certain actions without seller consent

Example Protections for Seller:

Buyer shall not, without seller's consent:
- Change pricing below prior year levels
- Reduce sales/marketing spend below $X
- Terminate key employees
- Merge acquired business with another division (for EBITDA earnouts)
- Change accounting policies that reduce earnout metrics

Seller Protections

📋 Detailed Definitions

Define earnout metrics with extreme precision. Reference specific accounting treatments. Leave no ambiguity.

🤝 Independent Audit

Require independent accounting firm to calculate earnout. Specify who pays (often split or loser pays).

🛡️ Negative Covenants

Restrict buyer from taking actions specifically to reduce earnout (e.g., can't slash marketing budget).

⚡ Acceleration Triggers

Earnout becomes due immediately if buyer sells business, merges, or takes other actions that prevent earnout achievement.

📊 Regular Reporting

Require buyer to provide monthly/quarterly financial reports showing progress toward earnout targets.

⚖️ Dispute Resolution

Clear mechanism for resolving earnout disputes (arbitration, expert determination, specific accounting firm).

Common Earnout Pitfalls

❌ Vague Metric Definitions

Problem: "EBITDA as reasonably determined by buyer"

Result: Disputes over what counts as EBITDA, how expenses are allocated, etc.

Fix: 10-page exhibit defining exactly how to calculate EBITDA, including treatment of every material expense category

❌ Buyer Complete Control Over Results

Problem: Buyer controls all decisions that affect earnout, with no seller protections

Result: Buyer makes decisions that harm earnout (cut marketing, slash prices, reallocate expenses)

Fix: Covenant requiring buyer to operate business consistently with past practices and restricting actions that impair earnout

❌ No Dispute Resolution Mechanism

Problem: Parties disagree on earnout calculation, no process to resolve

Result: Expensive litigation, relationship destroyed

Fix: Independent expert determination or arbitration by specified accounting firm, with specific timeline (30 days notice, 60 days to resolve)

❌ Unrealistic Targets

Problem: Earnout targets based on best-case projections, not realistic

Result: Seller never achieves earnout, feels cheated

Fix: Ensure targets are based on reasonable projections, historical trends, and market conditions. Consider sliding scale rather than all-or-nothing.

Sample Earnout Structures

Example 1: SaaS Revenue Earnout

Base Purchase Price: $50M (paid at close)

Earnout Structure:
Year 1: $5M if ARR ≥ $65M on 12/31/2025
Year 2: $10M if ARR ≥ $80M on 12/31/2026

Total Potential: $50M + $15M earnout = $65M

Definitions:
- ARR = Annual Recurring Revenue from subscriptions
- Calculated using seller's historical methodology
- Includes only committed contracts, not bookings
- New customer ARR and expansion ARR both count
- Does not include one-time fees or professional services

Seller Protections:
- Buyer cannot reduce pricing below prior year without seller consent
- Buyer maintains minimum $5M annual sales & marketing spend
- Seller CEO remains employed and has authority over sales team
- Independent audit by Deloitte within 45 days of year-end

Acceleration:
- If buyer sells the business, earnout immediately due at target amount
- If buyer terminates seller CEO without cause, earnout immediately due

Dispute Resolution:
- Disputes resolved by Deloitte within 30 days
- Each party submits calculation, Deloitte chooses one
- Losing party pays arbitration fees

Example 2: EBITDA Earnout with Sliding Scale

Base Purchase Price: $40M (paid at close)

Earnout Structure:
Cumulative 2-year EBITDA earnout on sliding scale:

$25-30M EBITDA: $0
$30-35M EBITDA: $1M per $1M above $30M (max $5M)
$35-40M EBITDA: Additional $1.5M per $1M above $35M (max $7.5M)
$40M+ EBITDA: Additional $2M per $1M above $40M (capped at $12.5M total)

Maximum Earnout: $12.5M
Total Potential: $52.5M

EBITDA Definition:
[10-page exhibit with precise definition including]:
- Follows seller's historical accounting practices
- Corporate overhead allocation capped at $400K/year
- Excludes acquisition-related expenses
- Excludes extraordinary items > $75K
- Capital lease adjustments specified
- Calculation methodology for intercompany transactions

Seller Protections:
- Business operates as separate division for earnout period
- No integration with other divisions without seller consent
- Overhead allocation limited to actual shared services
- Seller CFO reviews quarterly financials
- Cannot transfer key employees out of division

Acceleration:
- Full earnout due if buyer merges division with another
- Pro-rata earnout due if business sold before earnout period ends

Independent Audit:
- EY to calculate final EBITDA within 60 days of period end
- Parties each provide calculation, EY determines final number
- Decision is binding and final

Example 3: Milestone-Based Earnout (Biotech)

Base Purchase Price: $100M (paid at close)

Milestone Earnout Structure:
Milestone 1: $25M upon FDA approval of Product X (by 12/31/2026)
Milestone 2: $15M upon achieving $50M in Product X sales (by 12/31/2027)
Milestone 3: $10M upon EMA approval in Europe (by 12/31/2027)

Total Potential: $100M + $50M = $150M

Seller Protections:
- Buyer commits to spend minimum $10M annually on Product X development
- Buyer cannot abandon or significantly delay Product X development
- Seller representatives on Product X steering committee
- Buyer provides quarterly updates on development progress

Acceleration:
- If buyer abandons Product X development, all milestone payments due
- If buyer licenses Product X to third party, milestones accelerate
- If buyer is acquired, milestones accelerate pro-rata based on probability

Dispute Resolution:
- Disputes over milestone achievement resolved by industry expert
- Specified expert firm (Covington LLP life sciences practice)

Best Practices

The 10 Rules of Earnouts

  1. Keep It Simple: Fewer metrics, clearer definitions, less complexity
  2. Use Objective Metrics: Revenue > EBITDA > Subjective milestones
  3. Define Everything: 10-page definition of earnout calculation is not unusual
  4. Protect Both Sides: Balance buyer control with seller protections
  5. Independent Verification: Third-party audit required
  6. Reasonable Targets: Based on realistic projections, not best-case
  7. Appropriate Period: 2-3 years typical, match to business cycle
  8. Clear Dispute Process: Specify how disagreements will be resolved
  9. Consider Acceleration: What happens if buyer sells, merges, or materially changes business?
  10. Model It Out: Run scenarios - what happens if business grows 20%? Declines 20%?

References

  1. Earnout Structures in M&A - ABA
  2. Earnout Best Practices - Deloitte
  3. Avoiding Earnout Disputes - KPMG
  4. Earnout Litigation Trends - PwC
  5. M&A Earnouts Survey - SRS Acquiom

Last updated: Wed Jan 29 2025 19:00:00 GMT-0500 (Eastern Standard Time)